人民财讯8月4日电，据上交所企业上市服务公众号消息，上周(7月28日—8月3日)新增受理1家科创板企 业IPO。截至8月3日，今年新增IPO受理企业178家。各板块在审企业共301家。其中上交所66家(主板29 家，科创板37家)，深交所55家(主板26家，创业板29家)，北交所180家。 ...

Core Viewpoint - The new stock market has shifted from a "three highs" issuance model (high issuance price, high issuance P/E ratio, high oversubscription) to a "three lows" model (low issuance price, low issuance P/E ratio, low oversubscription) in the first half of the year, leading to a positive impact on the market [1][3][4]. Group 1: New Stock Market Trends - In the first half of the year, no new stocks experienced a decline in price after listing, resulting in a significant profit effect from new stock subscriptions, with 41 stocks showing a profit exceeding 10,000 yuan per subscription, accounting for 80% [1][9]. - The average issuance P/E ratio for new stocks has decreased significantly, with 51 new stocks listed at an average P/E ratio of 18.83 times, down from 22.87 times in the same period last year [3][7]. - The highest issuance P/E ratio among new stocks was 441.18 times for Kangxi Communication, while the lowest was 6.14 times for Haibo Sichuang, indicating a narrowing range of P/E ratios [3][4]. Group 2: Subscription and Oversubscription - The average subscription rate for new stocks has dropped significantly, with the average online subscription rate at 0.0289%, about half of last year's average [12][15]. - The total fundraising amount for new stocks in the first half of the year was 37.721 billion yuan, an increase from 32.493 billion yuan in the same period last year, but the oversubscription situation has decreased [16][20]. - Only 11 new stocks experienced oversubscription, representing 21.57% of the total, compared to 40.91% in the previous year [20]. Group 3: Regulatory Changes and Support for Unprofitable Companies - The China Securities Regulatory Commission (CSRC) has introduced new regulations to enhance the quality of listed companies and strictly regulate the use of raised funds, emphasizing that oversubscription funds should not be used for permanent working capital or repaying bank loans [17][18]. - Recent policies have been favorable for unprofitable companies seeking to go public, with the introduction of a third set of standards for the ChiNext board to support high-quality unprofitable innovative enterprises [23][24]. - In June, 5 out of 18 newly accepted IPOs on the Sci-Tech Innovation Board were unprofitable companies, indicating a growing acceptance of such firms in the capital market [24].

Group 1 - A total of 19 IPOs were accepted by Shenzhen and Beijing Stock Exchanges from June 23 to June 24, including 1 from Shenzhen Main Board, 4 from Shenzhen ChiNext, and 14 from Beijing Stock Exchange [1] - As of June 24, 2025, a total of 80 IPO projects have been accepted across the three major exchanges, with 14 from Shanghai, 17 from Shenzhen, and 49 from Beijing [2] Group 2 - Hangzhou Fu'en Co., Ltd. was accepted for IPO on Shenzhen Main Board on June 24, with a registered capital of 175 million yuan [3] - The company focuses on sustainable development and is a global supplier of eco-friendly fabrics, primarily producing recycled fabrics [4] - The controlling shareholder is Paiya Holdings, holding 36.57% of shares, with actual controllers being Wang Neili, Wang Xuelin, and Wang Enwei, collectively controlling 83.89% of voting rights [5] - The company reported revenues of 1.76 billion yuan in 2022, 1.52 billion yuan in 2023, and projected 1.81 billion yuan in 2024, with net profits of 276 million yuan, 227 million yuan, and 254 million yuan respectively [6][7] - The company meets the listing criteria of Shenzhen Stock Exchange, with positive net profits over the last three years and a cumulative net profit of no less than 200 million yuan [8] Group 3 - Suzhou Betterly Polymer Materials Co., Ltd. was accepted for IPO on ChiNext on June 24, with a registered capital of 197 million yuan [13] - The company specializes in the R&D, production, and sales of electronic materials and new chemical materials, with applications in photovoltaic, 3C electronics, and new energy vehicles [14] - The controlling shareholder is Wang Quan, holding 37.26% of shares, with actual control by Wang Quan and Ouyang Xufeng [15] - The company reported revenues of 635 million yuan in 2022, 2.27 billion yuan in 2023, and projected 2.52 billion yuan in 2024, with net profits of 13 million yuan, 84 million yuan, and 95 million yuan respectively [16][17] - The company meets the listing criteria of ChiNext, with positive net profits over the last two years and a cumulative net profit of no less than 100 million yuan [19] Group 4 - Nantong Lianya Pharmaceutical Co., Ltd. was accepted for IPO on ChiNext on June 24, with a registered capital of 757.86 million yuan [24] - The company is a R&D-driven high-tech enterprise focusing on complex drug formulations, primarily producing high-end generic drugs [26] - The controlling shareholder is Lianya Cayman, holding 22.62% of shares, with actual controllers being Zhang Guohua and others [27] - The company reported revenues of 550 million yuan in 2022, 700 million yuan in 2023, and projected 866 million yuan in 2024, with net profits of 68 million yuan, 87 million yuan, and 181 million yuan respectively [28][29] - The company meets the listing criteria with positive net profits over the last two years and a cumulative net profit of no less than 100 million yuan [30] Group 5 - Guizhou Southern Dairy Co., Ltd. was accepted for IPO on Beijing Stock Exchange on June 24, with a registered capital of 150 million yuan [35] - The company is engaged in the manufacturing and sales of dairy products and related beverages, including various low-temperature and room-temperature dairy products [36] - The controlling shareholder is Guiyang Agricultural Investment Group, holding 51.01% of shares, with significant influence from the Guiyang State-owned Assets Supervision and Administration Commission [37] - The company reported revenues of 1.58 billion yuan in 2022, 1.80 billion yuan in 2023, and projected 1.82 billion yuan in 2024, with net profits of 165 million yuan, 199 million yuan, and 207 million yuan respectively [38][39] - The company meets the listing criteria with a market value of no less than 200 million yuan and positive net profits over the last two years [40] Group 6 - Zhongjiankangqiao Pharmaceutical Group Co., Ltd. was accepted for IPO on Beijing Stock Exchange on June 24, with a registered capital of 75.40 million yuan [45] - The company focuses on chronic disease medications, particularly for cardiovascular diseases, and has established a comprehensive industry chain [46] - The controlling shareholder is Furong Kangda, holding 57.58% of shares, with actual controllers being Liu Zongjie and others [47] - The company reported revenues of 267 million yuan in 2022, 343 million yuan in 2023, and projected 446 million yuan in 2024, with net profits of 61 million yuan, 111 million yuan, and 103 million yuan respectively [48][49] - The company meets the listing criteria with a market value of no less than 200 million yuan and positive net profits over the last two years [51] Group 7 - Beijing Kangmite Technology Co., Ltd. was accepted for IPO on Beijing Stock Exchange on June 24, with a registered capital of 120.20 million yuan [56] - The company specializes in the R&D, production, and sales of electronic packaging materials and high-performance modified plastics [57]

Group 1 - The article discusses the recent acceptance of 12 IPO applications by the Shanghai, Shenzhen, and Beijing stock exchanges from June 19 to June 21, 2023 [1] - As of June 21, 2023, a total of 61 IPO projects have been accepted by the three exchanges, with 14 by the Shanghai Stock Exchange, 12 by the Shenzhen Stock Exchange, and 35 by the Beijing Stock Exchange [2] Group 2 Beijing Vito Electric Co., Ltd. - The company was established in October 2003 and transformed into a joint-stock company in September 2023, with a registered capital of 187 million yuan [3] - The main business includes the research, production, and sales of various electrical connection products [4] - The controlling shareholder, Huang Haoyun, holds 56.57% of the shares and controls a total of 68.33% of the voting rights [5] - The company reported revenues of 1.436 billion yuan, 1.699 billion yuan, and 2.390 billion yuan for 2022, 2023, and 2024 respectively, with net profits of 113 million yuan, 179 million yuan, and 270 million yuan [6][7] - The company plans to raise 1.594 billion yuan through its IPO for four projects, including the construction of a new production base [12] Guangxi Tianyuan Biochemical Co., Ltd. - The company was established in March 2001 and transformed into a joint-stock company in January 2002, with a registered capital of 105 million yuan [14] - The main business focuses on the research, production, and sales of pesticide formulations [15] - The controlling shareholder, Taihe Investment, holds 32.57% of the shares, while the actual controller, Li Weiguo, can control 45.08% of the voting rights [16] - The company reported revenues of 1.712 billion yuan, 1.774 billion yuan, and 1.750 billion yuan for 2022, 2023, and 2024 respectively, with net profits of 169 million yuan, 210 million yuan, and 227 million yuan [17][18] - The company aims to raise 629 million yuan through its IPO for five projects, including a green chemical processing center [24] Yifeng New Materials Co., Ltd. - Established in January 2011, the company has a registered capital of 142 million yuan [26] - The main business is focused on the research, production, and sales of optical new materials [27] - The controlling shareholder, Ma Yunsheng, holds 32.45% of the shares, while his spouse holds an additional 12.66% [28] - The company reported revenues of 714 million yuan, 625 million yuan, and 601 million yuan for 2022, 2023, and 2024 respectively, with net profits of 130 million yuan, 155 million yuan, and 133 million yuan [29][30] - The company plans to raise 844 million yuan through its IPO for five projects, including a high-refractive index optical resin material project [35] Shenzhen Aiwei Electric Technology Co., Ltd. - The company was established in October 2017 and transformed into a joint-stock company in December 2023, with a registered capital of 54.9 million yuan [37] - The main business provides digital control and power electronics products for new energy vehicles [38] - The controlling shareholder, Liang Xianghui, holds 47.89% of the shares and controls 56.09% of the voting rights [39] - The company reported revenues of 215 million yuan, 341 million yuan, and 442 million yuan for 2022, 2023, and 2024 respectively, with net profits of 57 million yuan, 85 million yuan, and 102 million yuan [40][41] - The company aims to raise 930 million yuan through its IPO for three projects, including a smart manufacturing base for high-voltage control components [45] Wuhu Aiteke Automotive Electronics Co., Ltd. - The company was established in December 2002 and transformed into a joint-stock company in December 2022, with a registered capital of 134.32 million yuan [55] - The main business focuses on providing intelligent solutions for automotive electronics [56]

Group 1 - The number of newly accepted IPO applications last week was 20 [1] - Among the new IPO applications, there was 1 from the Shanghai Stock Exchange main board, 3 from the Sci-Tech Innovation Board, 2 from the Shenzhen Stock Exchange main board, 4 from the Growth Enterprise Market, and 10 from the Beijing Stock Exchange [1] - As of June 22, a total of 61 new IPO applications have been accepted this year [1] Group 2 - There are currently 208 companies under review for IPOs across various boards [1] - The breakdown of companies under review includes 52 from the Shanghai Stock Exchange (27 from the main board and 25 from the Sci-Tech Innovation Board), 45 from the Shenzhen Stock Exchange (23 from the main board and 22 from the Growth Enterprise Market), and 111 from the Beijing Stock Exchange [1]